All Stories

  1. Data from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  2. Supplementary Figure S1 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  3. Supplementary Figure S2 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  4. Supplementary Figure S3 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  5. Supplementary Figure S4 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  6. Supplementary Table S1 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  7. Supplementary Table S2 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  8. Supplementary Table S3 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  9. Supplementary Table S4 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  10. Supplementary Table S5 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  11. Supplementary Table S6 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  12. Supplementary Table S7 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  13. An integrated PET/CT simulation framework for virtual imaging trials and quantitative performance evaluation
  14. Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  15. Scale-aware adaptive supervised network with limited medical annotations
  16. VisionUnite: A Vision-Language Foundation Model for Ophthalmology Enhanced With Clinical Knowledge
  17. Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group
  18. The emergence of PET/CT: Engineering, innovation, and usage
  19. Regularizing the Deepsurv Network Using Projection Loss for Medical Risk Assessment
  20. Timing, energy, and 3D spatial resolution of the BING PET detector module
  21. Synthetic PET via Domain Translation of 3D MRI
  22. Standards, Phantoms, and Site Qualification
  23. Impact of Using Uniform Attenuation Coefficients for Heterogeneously Dense Breasts in a Dedicated Breast PET/X-Ray Scanner
  24. Deep learning-based model observers that replicate human observers for PET imaging
  25. The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy
  26. PET/CT-guided biopsy with respiratory motion correction
  27. Task Group 174 Report: Utilization of [ 18 F]Fluorodeoxyglucose Positron Emission Tomography ([ 18 F]FDG‐PET) in Radiation Therapy
  28. Improved model prediction of glioma growth utilizing tissue-specific boundary effects
  29. Performance evaluation of the 5‐Ring GE Discovery MI PET/CT system using the national electrical manufacturers association NU 2‐2012 Standard
  30. Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging
  31. Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control study
  32. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules
  33. Erratum: Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network
  34. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II
  35. Bias in PET Images of Solid Phantoms Due to CT-Based Attenuation Correction
  36. Special Section Guest Editorial: Artificial Intelligence in Medical Imaging
  37. The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective
  38. Test–Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
  39. The PET/X dedicated breast-PET scanner for optimizing cancer therapy
  40. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project
  41. Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer
  42. Simulating magnetic resonance images based on a model of tumor growth incorporating microenvironment
  43. Deep-learning derived features for lung nodule classification with limited datasets
  44. Multicenter survey of PET/CT protocol parameters that affect standardized uptake values
  45. Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy
  46. Simulation study of quantitative precision of the PET/X dedicated breast PET scanner
  47. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy
  48. Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network
  49. Demonstration of PET System Design Trade-offs Using Small Lesion Detectability as a Metric and Measured Phantom Data
  50. Impact of Patient Size on Image Quality in Clinical PET with a Convergent Penalized-Likelihood Image Reconstruction Algorithm
  51. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy
  52. A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy
  53. Special Section Guest Editorial: Positron Emission Tomography: History, Current Status, and Future Prospects
  54. A phantom design and assessment of lesion detectability in PET imaging
  55. Improved attenuation correction for respiratory gated PET/CT with extended-duration cine CT: a simulation study
  56. Statistical distributions of ultra-low dose CT sinograms and their fundamental limits
  57. Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry
  58. Qualification of National Cancer Institute–Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
  59. Comparison Between Pre-Log and Post-Log Statistical Models in Ultra-Low-Dose CT Reconstruction
  60. Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data
  61. Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program
  62. Direct Reconstruction of CT-based Attenuation Correction Images for PET with Cluster-Based Penalties
  63. Evaluation of lesion detectability in positron emission tomography when using a convergent penalized likelihood image reconstruction method
  64. Evaluation of event position reconstruction in monolithic crystals that are optically coupled
  65. Fast analytical approach of application specific dose efficient spectrum selection for diagnostic CT imaging and PET attenuation correction
  66. Mixed Confidence Estimation for Iterative CT Reconstruction
  67. A phantom design for assessment of detectability in PET imaging
  68. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans
  69. Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients
  70. Characterization of PET/CT images using texture analysis: the past, the present… any future?
  71. Designing a compact high performance brain PET scanner—simulation study
  72. Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims
  73. Radiomics: Images Are More than Pictures, They Are Data
  74. Quantitative Imaging in Cancer Clinical Trials
  75. An algorithm for automated ROI definition in water or epoxy-filled NEMA NU-2 image quality phantoms
  76. Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems
  77. Cherenkov luminescence measurements with digital silicon photomultipliers: a feasibility study
  78. Addendum to ‘A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using18F-FMISO-PET’
  79. A Digital Reference Object to Analyze Calculation Accuracy of PET Standardized Uptake Value
  80. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
  81. A phantom design for assessment of detectability using a lumpy background and 3D-printed features
  82. An improved statistical approach to the estimation of spatial bias and variability in reconstructed PET data
  83. Simulation study for designing a compact brain PET scanner
  84. Ultra-low dose CT attenuation correction for PET/CT: analysis of sparse view data acquisition and reconstruction algorithms
  85. AAPM/SNMMI Joint Task Force: report on the current state of nuclear medicine physics training
  86. Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards
  87. In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
  88. The Value of Establishing the Quantitative Accuracy of PET/CT Imaging
  89. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies
  90. Performance assessment of a NaI(Tl) gamma counter for PET applications with methods for improved quantitative accuracy and greater standardization
  91. Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients
  92. Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study
  93. Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
  94. Improving lesion detectability in PET imaging with a penalized likelihood reconstruction algorithm
  95. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET
  96. Impact of CT attenuation correction method on quantitative respiratory-correlated (4D) PET/CT imaging
  97. Analysis of statistical models for iterative reconstruction of extremely low-dose CT data
  98. Comparison between pre-log and post-log statistical models in low-dose CT iterative reconstruction
  99. Improving lesion detectability in low uptake 18 F-FDG breast cancer by optimizing PET imaging time
  100. Spatial covariance characteristics in a collection of 3-D PET scanners used in clinical imaging trials
  101. Statistical comparison of likelihood models for low dose x-ray CT
  102. Multimodality molecular imaging of the lung
  103. An OpenPET scanner with bridged detectors to compensate for incomplete data
  104. Assessment of patient selection criteria for quantitative imaging with respiratory-gated positron emission tomography
  105. Multiplexing strategies for monolithic crystal PET detector modules
  106. Letter to Cancer Center Directors: Progress in Quantitative Imaging As a Means to Predict and/or Measure Tumor Response in Cancer Therapy Trials
  107. Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons
  108. Meta-analysis of the technical performance of an imaging procedure: Guidelines and statistical methodology
  109. X-ray pulsing methods for reduced-dose computed tomography in PET/CT attenuation correction
  110. Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification
  111. Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling
  112. Variations of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Evaluation of Breast Cancer Therapy Response: A Multicenter Data Analysis Challenge
  113. A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment
  114. Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements
  115. Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive
  116. Dual energy CT for attenuation correction with PET/CT
  117. Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: Effects of differential measurement error and bias on power calculations for unselected and enrichment designs
  118. A digital reference object for the 3D Hoffman brain phantom for characterization of PET neuroimaging quality
  119. Analysis of optimal CT spectrum for PET attenuation correction
  120. Direct reconstruction of CT-based attenuation correction images for PET with cluster-based penalties
  121. Effects of Detector Thickness on Geometric Sensitivity and Event Positioning Errors in the Rectangular PET/X Scanner
  122. Experimental evaluation of a deformable registration algorithm for motion correction in PET-CT guided biopsy
  123. Image reconstruction in rectangular PET systems using distance-driven projections
  124. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures
  125. Overview and a Word of Thanks
  126. SU-C-141-04: Robustness of 4DCT and 4DCBCT Object Volume Measurement with a Motion-Capable Lung Phantom That Mimics Realistic Patient Tumor Trajectories
  127. SU-D-141-06: Patient-Specific Imaging and Dosimetric Errors in PET/CT-Guided Radiotherapy of Lung Cancer
  128. TU-A-141-01: Multi Modal PET/CT Imaging for Therapy Response Early Prediction and Therapy Monitoring
  129. TU-E-141-09: Impact of Attenuation Correction Mode On 4D PET/CT for Target Definition in Lung Cancer Patients
  130. Model-Based Iterative Reconstruction Versus Adaptive Statistical Iterative Reconstruction and Filtered Back Projection in Liver 64-MDCT: Focal Lesion Detection, Lesion Conspicuity, and Image Noise
  131. Quantitative assessment of dynamic PET imaging data in cancer imaging
  132. Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials
  133. Enhancing clinical utility of respiratory-gated PET/CT using patient respiratory trace classification
  134. Detector position estimation for PET scanners
  135. MO-A-BRA-01: State of the Art in Quantitative Imaging in CT, PET and MRI
  136. TU-C-217BCD-01: Where Molecular Imaging Is Taking Us
  137. Accuracy of CT-based attenuation correction in PET/CT bone imaging
  138. Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials
  139. Design Considerations for using PET as a Response Measure in Single Site and Multicenter Clinical Trials
  140. Introduction and a Word of Thanks
  141. Ultra-low dose CT attenuation correction for PET/CT
  142. Dual-radioisotope PET data acquisition and analysis
  143. Resolution Properties of a Prototype Continuous Miniature Crystal Element (cMiCE) Scanner
  144. Properties and Mitigation of Edge Artifacts in PSF-Based PET Reconstruction
  145. Effective count rates for PET scanners with reduced and extended axial field of view
  146. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images
  147. A robust state-space kinetics-guided framework for dynamic PET image reconstruction
  148. Quantifying and Reducing the Effect of Calibration Error on Variability of PET/CT Standardized Uptake Value Measurements
  149. Respiratory motion correction for quantitative PET/CT using all detected events with internal—external motion correlation
  150. Effects of MR surface coils on PET quantification
  151. DOI-based reconstruction algorithms for a compact breast PET scanner
  152. Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy
  153. Multimodality molecular imaging of the lung
  154. Resolution properties of a prototype continuous miniature crystal element (cMiCE) scanner
  155. Properties of edge artifacts in PSF-based PET reconstruction
  156. Image reconstruction for PET/CT scanners: past achievements and future challenges
  157. SU-GG-J-142: Investigation of MIP PET in Motion-Encompassing Methods to Account for Respiratory Motion in Radiotherapy
  158. TU-C-201C-02: Physical Validation of PET/CT for Imaging as a Biomarker
  159. Advancements to the planogram frequency–distance rebinning algorithm
  160. Noise and bias properties of monoenergetic images from DECT used for attenuation correction with PET/CT and SPECT/CT
  161. Application and Evaluation of a Measured Spatially Variant System Model for PET Image Reconstruction
  162. Noise and signal properties in PSF-based fully 3D PET image reconstruction: an experimental evaluation
  163. Variability in PET quantitation within a multicenter consortium
  164. Quiescent period respiratory gating for PET/CT
  165. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT
  166. Attenuation-emission alignment in cardiac PET/CT based on consistency conditions
  167. Quantitative Imaging to Assess Tumor Response to Therapy: Common Themes of Measurement, Truth Data, and Error Sources
  168. PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data and Error
  169. The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging
  170. Statistical Sinogram Restoration in Dual-Energy CT for PET Attenuation Correction
  171. Statistical LOR estimation for a high-resolution dMiCE PET detector
  172. Limits of ultra-low dose CT attenuation correction for PET/CT
  173. Impact on Image Noise of Incorporating Detector Blurring Into Image Reconstruction for a Small Animal PET Scanner
  174. Fast kVp-switching dual energy CT for PET attenuation correction
  175. Evaluation of noise properties in PSF-based PET image reconstruction
  176. Determining block detector positions for PET scanners
  177. Weight-Based, Low-Dose Pediatric Whole-Body PET/CT Protocols
  178. Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II
  179. Statistical three-dimensional positioning algorithm for high-resolution dMiCE PET detector
  180. Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II
  181. The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change-Analysis Software
  182. Planogram Rebinning With the Frequency-Distance Relationship
  183. Measured count-rate performance of the Discovery STE PET/CT scanner in 2D, 3D and partial collimation acquisition modes
  184. Image Reconstruction for a Partially Collimated Whole Body PET Scanner
  185. Application of a spatially variant system model for 3-D whole-body pet image reconstruction
  186. Low-dose dual-energy computed tomography for PET attenuation correction with statistical sinogram restoration
  187. Gas Bubble Motion Artifact in MDCT
  188. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements
  189. Quantification of radiotracer uptake with a dedicated breast PET imaging system
  190. Statistical image reconstruction from correlated data with applications to PET
  191. Effect of Reconstruction Algorithms on Myocardial Blood Flow Measurement with 13N-Ammonia PET
  192. Optimization of Noise Equivalent Count Rate Performance for a Partially Collimated PET Scanner by Varying the Number of Septa
  193. Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
  194. Cine CT for Attenuation Correction in Cardiac PET/CT
  195. Evaluation of Multiclass Model Observers in PET LROC Studies
  196. Reproducibility of quantifying tracer uptake with PET/CT for evaluation of response to therapy
  197. Expanding SimSET to include block detectors: performance with pseudo-blocks and a true block model
  198. Estimating live-time for new PET scanner configurations
  199. Consistency driven respiratory phase alignment and motion compensation in PET/CT
  200. Accuracy of CT-Based attenuation correction in bone imaging with PET/CT
  201. A generalized simulation description language
  202. Automatic arm removal in PET and CT images for deformable registration
  203. Dual Energy CT Attenuation Correction Methods for Quantitative Assessment of Response to Cancer Therapy with PET/CT Imaging
  204. Modeling and incorporation of system response functions in 3-D whole body PET
  205. Numerical observer studies comparing FORE+AWOSEM, FORE+NECOSEM and NEC based fully 3-D OSEM for 3-D whole-body PET imaging
  206. [11C]Metahydroxyephedrine and [18F]Fluorodeoxyglucose Positron Emission Tomography Improve Clinical Decision Making in Suspected Pheochromocytoma
  207. Simulations of the Effect of Collimation on Count Rates of an LSO PET System
  208. Improved PET Detection of Focal Brain Activity Using Subset-dependent Relaxation `Dynamic' Row-action Maximum Likelihood Algorithm (DRAMA)
  209. Count-Rate Performance of the Discovery STE PET Scanner Using Partial Collimation
  210. Tumor delineation using PET in head and neck cancers: Threshold contouring and lesion volumes
  211. Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors
  212. Attenuation-Emission Alignment in Cardiac PET/CT with Consistency Conditions
  213. Analytical reconstruction of deconvolved Fourier rebinned PET sinograms
  214. SU-FF-J-106: FMISO-PET Hypoxia Imaging: A Novel Method to Plan IMRT-Based Boost Radiation to Hypoxic Subvolumes
  215. SU-FF-J-107: Tumor-Delineation Uncertainties in FDG-PET and FMISO-PET Images and the Effect On Radiation Therapy Plans
  216. Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors
  217. Simulation of countrate performance for a PET scanner with partial collimation
  218. Effect of patient thickness and scan duration on lesion detectability in PET oncology imaging
  219. Advanced PET/CT fusion workstation for oncology imaging
  220. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation
  221. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
  222. PET/CT scanner instrumentation, challenges, and solutions
  223. PET instrumentation
  224. Distribution of 1-(2-Deoxy-2-fluoro- -D-arabinofuranosyl) Uracil in Mice Bearing Colorectal Cancer Xenografts: Rationale for Therapeutic Use and as a Positron Emission Tomography Probe for Thymidylate Synthase
  225. Pragmatic fully 3D image reconstruction for the MiCES mouse imaging PET scanner
  226. Volumetric model and human observer comparisons of tumor detection for whole-body positron emission tomography1
  227. Fast Fully 3-D Image Reconstruction in PET Using Planograms
  228. Impact of System Design Parameters on Image Figures of Merit for a Mouse PET Scanner
  229. A Comparison of Planar Versus Volumetric Numerical Observers for Detection Task Performance in Whole-Body PET Imaging
  230. Analytic Image Reconstruction Methods
  231. Fast PET EM Reconstruction From Linograms
  232. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners
  233. Weight Loss-Induced Plasticity of Glucose Transport and Phosphorylation in the Insulin Resistance of Obesity and Type 2 Diabetes
  234. Performance comparisons of planar and volumetric observers for lesion detection in PET scanning
  235. Postinjection single photon transmission tomography with ordered-subset algorithms for whole-body PET imaging
  236. Clinically feasible reconstruction of 3D whole-body PET/CT data using blurred anatomical labels
  237. Comparison of 3-D reconstruction with 3D-OSEM and with FORE+OSEM for PET
  238. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
  239. Combined PET/CT Imaging in Oncology Impact on Patient Management
  240. Image Analysis in Patients with Cancer Studied with a Combined PET and CT Scanner
  241. PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum
  242. A Direct Comparison between Whole-Brain PET and BOLD fMRI Measurements of Single-Subject Activation Response
  243. Attenuation correction for a combined 3D PET/CT scanner
  244. Exact and approximate rebinning algorithms for 3-D PET data
  245. Statistical image reconstruction in PET with compensation for missing data
  246. A comparison of transform and iterative reconstruction techniques for a volume-imaging PET scanner with a large axial acceptance angle
  247. Basal Ganglia Studies with 3D Acquisition and 2D Reconstruction on a Retractable Septa PET Scanner
  248. The performance of the single-slice rebinning technique for imaging the human striatum as evaluated bp phantom studies
  249. Figures of merit for comparing reconstruction algorithms with a volume-imaging PET scanner
  250. Evaluation of task-oriented performance of several fully 3D PET reconstruction algorithms
  251. A methodology for testing for statistically significant differences between fully 3D PET reconstruction algorithms
  252. [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomography
  253. Effect of increased axial field of view on the performance of a volume PET scanner
  254. Positron emission tomography with a large axial acceptance angle: signal-to-noise considerations
  255. Position estimation and error correction in a 2D position-sensitive NaI(Tl) detector
  256. Toward the design of a positron volume imaging camera
  257. Analytic 3D image reconstruction using all detected events
  258. Three-dimensional image reconstruction in object space
  259. Conceptual design of a whole body PET machine
  260. The Theory of Three-Dimensional Image Reconstruction for PET
  261. A teachable neural network based on an unorthodox neuron
  262. The Effects of Object Size, Attenuation, Scatter, and Random Coincidences on Signal to Noise Ratio in Simulations of Time-of-Flight Positron Emission Tomography
  263. Simulation of Countrate Performance for a PET Scanner with Different Degrees of Partial Collimation
  264. Measured Spatially Variant System Response for PET Image Reconstruction
  265. A Quantitative Approach to a Weight-Based Scanning Protocol for PET Oncology Imaging
  266. Correction methods for random coincidences in 3D wholebody PET imaging
  267. The effect of attenuation on lesion detection in PET oncology
  268. Quantitative attenuation correction for PET/CT using iterative reconstruction of low-dose dual-energy CT